Chargement en cours...
Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia
Acute myeloid leukemia (AML) is a blood cancer that is poorly responsive to conventional cytotoxic chemotherapy and a diagnosis of AML is usually fatal. More effective and better-tolerated therapies for AML are desperately needed. Activating mutations in FMS-like tyrosine kinase 3 (FLT3) are one of...
Enregistré dans:
| Publié dans: | Exp Hematol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5815916/ https://ncbi.nlm.nih.gov/pubmed/28947392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2017.09.007 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|